chr2-237387663-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004369.4(COL6A3):​c.1231C>G​(p.Leu411Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00535 in 1,613,786 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0055 ( 37 hom. )

Consequence

COL6A3
NM_004369.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.51

Publications

7 publications found
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]
COL6A3 Gene-Disease associations (from GenCC):
  • Bethlem myopathy 1A
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1C
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • dystonia 27
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AR, AD, SD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010365635).
BP6
Variant 2-237387663-G-C is Benign according to our data. Variant chr2-237387663-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 94903.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00383 (584/152300) while in subpopulation NFE AF = 0.0054 (367/68014). AF 95% confidence interval is 0.00494. There are 2 homozygotes in GnomAd4. There are 277 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004369.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A3
NM_004369.4
MANE Select
c.1231C>Gp.Leu411Val
missense
Exon 4 of 44NP_004360.2
COL6A3
NM_057167.4
c.613C>Gp.Leu205Val
missense
Exon 3 of 43NP_476508.2
COL6A3
NM_057165.5
c.613C>Gp.Leu205Val
missense
Exon 3 of 8NP_476506.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A3
ENST00000295550.9
TSL:1 MANE Select
c.1231C>Gp.Leu411Val
missense
Exon 4 of 44ENSP00000295550.4
COL6A3
ENST00000392004.7
TSL:1
c.613C>Gp.Leu205Val
missense
Exon 3 of 8ENSP00000375861.3
COL6A3
ENST00000433762.1
TSL:1
c.1231C>Gp.Leu411Val
missense
Exon 4 of 6ENSP00000389539.1

Frequencies

GnomAD3 genomes
AF:
0.00384
AC:
584
AN:
152182
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00133
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.0161
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00540
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00396
AC:
991
AN:
250414
AF XY:
0.00412
show subpopulations
Gnomad AFR exome
AF:
0.00118
Gnomad AMR exome
AF:
0.00197
Gnomad ASJ exome
AF:
0.0191
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00134
Gnomad NFE exome
AF:
0.00552
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.00551
AC:
8053
AN:
1461486
Hom.:
37
Cov.:
32
AF XY:
0.00535
AC XY:
3887
AN XY:
726994
show subpopulations
African (AFR)
AF:
0.00111
AC:
37
AN:
33474
American (AMR)
AF:
0.00201
AC:
90
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.0168
AC:
440
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.00122
AC:
105
AN:
86166
European-Finnish (FIN)
AF:
0.00101
AC:
54
AN:
53392
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.00627
AC:
6970
AN:
1111830
Other (OTH)
AF:
0.00576
AC:
348
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
508
1016
1524
2032
2540
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00383
AC:
584
AN:
152300
Hom.:
2
Cov.:
33
AF XY:
0.00372
AC XY:
277
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00132
AC:
55
AN:
41572
American (AMR)
AF:
0.00431
AC:
66
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0161
AC:
56
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4826
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00540
AC:
367
AN:
68014
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00626
Hom.:
4
Bravo
AF:
0.00377
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00882
AC:
34
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00616
AC:
53
ExAC
AF:
0.00359
AC:
436
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00709
EpiControl
AF:
0.00548

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Nov 05, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COL6A3: BP4, BS2

Bethlem myopathy 1A Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Collagen 6-related myopathy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
20
DANN
Benign
0.90
DEOGEN2
Benign
0.19
T
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.12
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.69
T
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.010
T
MetaSVM
Benign
-0.49
T
MutationAssessor
Benign
1.5
L
PhyloP100
1.5
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.68
N
REVEL
Benign
0.22
Sift
Benign
0.22
T
Sift4G
Benign
0.29
T
Polyphen
0.30
B
Vest4
0.11
MVP
0.74
MPC
0.35
ClinPred
0.0073
T
GERP RS
1.8
Varity_R
0.071
gMVP
0.31
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113716915; hg19: chr2-238296306; API